Fed. Circ. Reverses Patent Priority Rulings On Protein

By Melissa Lipman

Law360, New York (September 08, 2010, 3:46 PM ET) -- A federal appeals court has ruled that a patent application must do more than simply allow someone skilled in a field to envision an invention in order to lay claim to priority to the technology, reversing two interference decisions over an antiviral protein.

The U.S. Court of Appeals for the Federal Circuit gave priority on two interferences related to human fibroblast interferon to David V. Goeddel and Roberto Crea on Tuesday, overturning decisions by the U.S. Patent and Trademark Office's Board of Patent Appeals and Interferences....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles